<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CADASIL is an early <z:hpo ids='HP_0003674'>onset</z:hpo> small vessel disease and genetic variant of pure subcortical ischemic vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (SIVD) </plain></SENT>
<SENT sid="1" pm="."><plain>The condition has been invaluable in defining the profile and neuroimaging correlates of <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> in pure SIVD </plain></SENT>
<SENT sid="2" pm="."><plain>The recent completion of a randomized trial in cognitively impaired CADASIL patients has illustrated the feasibility of targeted therapeutic trials in narrowly defined subtypes of vascular <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This article highlights some of the advances on cognition in CADASIL </plain></SENT>
</text></document>